Research map: Sodium-Glucose Cotransporter-2 Inhibitors in Valvular Heart Disease: From Mechanistic Insights to Clinical Application
Back to the article
Papers in this map
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
· John J.V. McMurray · 2019 · 7146 citations · Cited by this paper
The Catheterization Laboratory: An Occupational Anachronism
· 2026 · Related
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
· Milton Packer · 2020 · 5221 citations · Cited by this paper
Percutaneous Mechanical Aspiration of Left-Sided Intracardiac Masses for Prohibitive Surgical Candidates: A Single-Center Experience
· 2026 · Related
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
· Michael J. Mack · 2019 · 4901 citations · Cited by this paper
Augmented Reality Ultrasound-Guided Vascular Access via Apple Vision Pro
· 2026 · Related
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
· Stefan D. Anker · 2021 · 4865 citations · Cited by this paper
Balloon Rupture During Balloon-Expandable TAVR: Insights Into the Role of Calcium Distribution and Lesion Preparation From Two Cases
· 2026 · Related
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
· Gregg W. Stone · 2018 · 2990 citations · Cited by this paper
Enhanced Radiation Protection Devices in Every Fluoroscopic Laboratory: A Call to Action
· 2026 · Related
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
· Scott David Solomon · 2022 · 2871 citations · Cited by this paper
A Hemodynamic Scoring System for Optimizing Transcatheter Arterialization of the Deep Veins in No-Option Patients With Chronic Limb-Threatening Ischemia
· 2026 · Related
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
· Yun‐Hee Youm · 2015 · 2174 citations · Cited by this paper
Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype
· 2026 · Related
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
· Deepak L. Bhatt · 2020 · 1873 citations · Cited by this paper
Gender Disparities Among Mitral Transcatheter Edge-to-Edge Repair and Transcatheter Mitral Valve Replacement Operators in the United States
· 2026 · Related
Right Ventricular Function in Cardiovascular Disease, Part II
· François Haddad · 2008 · 1301 citations · Cited by this paper
Artificial Intelligence–Derived Coronary Physiology Comes of Age—Promises, Precision, and Pragmatism in the Cath Lab
· 2026 · Related
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
· Ele Ferrannini · 2014 · 1145 citations · Cited by this paper
Pulmonary Embolism in the United States: A Report From the National PERT Consortium
· 2026 · Related
Targeting the unfolded protein response in disease
· Claudio A. Hetz · 2013 · 921 citations · Cited by this paper
Transcatheter Repair for Patients with Tricuspid Regurgitation
· Paul Sorajja · 2023 · 917 citations · Cited by this paper
Pathological Ventricular Remodeling
· Jana S. Burchfield · 2013 · 774 citations · Cited by this paper
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
· Eiki Takimoto · 2006 · 771 citations · Cited by this paper
Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
· Antonius Baartscheer · 2016 · 671 citations · Cited by this paper
Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
· Tsung‐Ming Lee · 2017 · 508 citations · Cited by this paper
SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
· Liang Xu · 2017 · 507 citations · Cited by this paper
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis
· K. Melissa Hallow · 2017 · 490 citations · Cited by this paper
Valvular Myofibroblast Activation by Transforming Growth Factor-β
· Gennyne A. Walker · 2004 · 402 citations · Cited by this paper
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
· C. David Mazer · 2019 · 370 citations · Cited by this paper
Effect of Sodium‐Glucose Cotransport‐2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of 43 Randomized Control Trials With 22 528 Patients
· Mohsen Mazidi · 2017 · 356 citations · Cited by this paper
Cellular Mechanisms of Aortic Valve Calcification
· Jane A. Leopold · 2012 · 262 citations · Cited by this paper
Empagliflozin Reduces Ca/Calmodulin-Dependent Kinase II Activity in Isolated Ventricular Cardiomyocytes
· Julian Mustroph · 2018 · 241 citations · Cited by this paper
SGLT2 Inhibitor–Induced Sympathoinhibition
· Lakshini Yasaswi Herat · 2020 · 237 citations · Cited by this paper
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure
· Milton Packer · 2017 · 232 citations · Cited by this paper
Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF‐β/Smad signalling in type 2 diabetic rats
· Jingjing Tian · 2021 · 213 citations · Cited by this paper
The Acute Hemodynamic Effects of MitraClip Therapy
· Robert James Siegel · 2011 · 203 citations · Cited by this paper
Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload
· Alexander Meyer · 2011 · 202 citations · Cited by this paper
Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure
· Nikole J. Byrne · 2017 · 176 citations · Cited by this paper
Source: OpenAlex (CC0)